Development of a nanoemulsion-adjuvanted prophylactic HSV-2 vaccine
Ended Project Grant Awarded Last action
- Award ID
- R44AI126964
- Recipient
-
Bluewillow Biologics Inc. UEI RL3UZ5ZDKFT8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,389,481
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Michigan, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1,084,225 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $987,515 | |
| Amendment | $0 | |
| Amendment | $994,743 | |
| Amendment | $0 | |
| Amendment | $998,684 | |
| Amendment | $0 | |
| Amendment | $694,683 | |
| Original award | $798,081 |
Show all 12
Quick answers
Who received award R44AI126964?
R44AI126964 was awarded to Bluewillow Biologics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 23, 2017.
How much is award R44AI126964 worth?
$3,389,481 has been obligated on R44AI126964.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award